When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed […] Read more
Experimental model systems are an indispensable part of research into SCLC. At the International Association for the Study of Lung Cancer’s 2021 Hot Topic Meeting: Small Cell Lung Cancer, keynote […] Read more
CDX Models Help Bring Personalized Treatment for SCLC a Step Closer
Leah Lawrence+more
A growing body of research in SCLC has revealed greater phenotypic heterogeneity within this disease than previously realized. Circulating-tumor-cell-derived explant models (CDX) are providing researchers with a resource to facilitate […] Read more
Preconditioning Program Shortens Postsurgical Hospital Stay for People with Lung Cancer
Beth Fand IncollingoReducing complications after lung cancer surgery could generate positive changes across healthcare, from better outcomes and quality of life to cost savings. Even a small decrease in incidence of postoperative […] Read more
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
Lynette M. Sholl, MDLynette M. Sholl, MD, Chief of Thoracic Pathology and Associate Director of the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and Associate Professor at Harvard Medical School, […] Read more
Novel RET Inhibitors Promising in Chinese Patients with RET-fusion Positive NSCLC
Leah LawrenceThe results of two studies presented at the 2021 World Conference on Lung Cancer—LIBRETTO-321 and ARROW—indicate that the selective RET inhibitors selpercatinib and pralsetinib are promising treatment options for patients […] Read more
Use of platinum-doublet chemotherapy regimen as second-line treatment for patients with relapsed small-cell lung cancer (SCLC) was a reasonable option compared with nonplatinum-based regimens, according to data from a meta-analysis […] Read more
Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030
Raymond U. Osarogiagbon, MBBS, FACPThe Baptist Cancer Center in Memphis, Tennessee, has launched a new initiative that comprises seven components that will address prevention, diagnosis, and treatment of lung cancer through smoking cessation, low-dose […] Read more
Two large-scale, randomized controlled trials—the U.S. National Lung Screening Trial (NLST; n = 53,454) and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON; n = 15,792)—have demonstrated that lung cancer […] Read more
Data from multiple groups1,2 have shown the significant impact of COVID-19 infection among patients with malignancies, leading to high overall morbidity and mortality; this includes our own institution,3 which saw […] Read more